JATT Acquisition (JATT) Competitors $1.28 +0.20 (+18.52%) As of 03/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends JATT vs. PEPG, JSPR, ZURA, IFRX, VTGN, SKYE, ABOS, MGX, ASRT, and ENTXShould you be buying JATT Acquisition stock or one of its competitors? The main competitors of JATT Acquisition include PepGen (PEPG), Jasper Therapeutics (JSPR), Zura Bio (ZURA), InflaRx (IFRX), Vistagen Therapeutics (VTGN), Skye Bioscience (SKYE), Acumen Pharmaceuticals (ABOS), Metagenomi (MGX), Assertio (ASRT), and Entera Bio (ENTX). These companies are all part of the "pharmaceutical products" industry. JATT Acquisition vs. PepGen Jasper Therapeutics Zura Bio InflaRx Vistagen Therapeutics Skye Bioscience Acumen Pharmaceuticals Metagenomi Assertio Entera Bio JATT Acquisition (NYSE:JATT) and PepGen (NASDAQ:PEPG) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Do analysts recommend JATT or PEPG? PepGen has a consensus target price of $10.33, suggesting a potential upside of 374.01%. Given PepGen's stronger consensus rating and higher probable upside, analysts clearly believe PepGen is more favorable than JATT Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score JATT Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PepGen 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media refer more to JATT or PEPG? In the previous week, PepGen had 2 more articles in the media than JATT Acquisition. MarketBeat recorded 3 mentions for PepGen and 1 mentions for JATT Acquisition. PepGen's average media sentiment score of 0.40 beat JATT Acquisition's score of 0.00 indicating that PepGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment JATT Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PepGen 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher valuation & earnings, JATT or PEPG? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/APepGenN/AN/A-$78.63M-$2.84-0.77 Do institutionals and insiders believe in JATT or PEPG? 48.0% of JATT Acquisition shares are held by institutional investors. Comparatively, 58.0% of PepGen shares are held by institutional investors. 20.0% of JATT Acquisition shares are held by company insiders. Comparatively, 4.6% of PepGen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is JATT or PEPG more profitable? JATT Acquisition's return on equity of -49.58% beat PepGen's return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% PepGen N/A -60.17%-48.88% Does the MarketBeat Community favor JATT or PEPG? PepGen received 20 more outperform votes than JATT Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformJATT AcquisitionN/AN/APepGenOutperform Votes2080.00% Underperform Votes520.00% SummaryPepGen beats JATT Acquisition on 7 of the 11 factors compared between the two stocks. Remove Ads Get JATT Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for JATT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JATT vs. The Competition Export to ExcelMetricJATT AcquisitionBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$22.08M$3.10B$5.74B$19.50BDividend YieldN/A1.52%4.41%3.83%P/E RatioN/A28.1324.0333.36Price / SalesN/A417.56398.0426.64Price / Cash27.08168.6838.1117.55Price / Book-2.423.416.824.53Net Income$6.85M-$71.72M$3.19B$1.02B7 Day Performance4.92%-2.63%-0.21%1.47%1 Month Performance-15.23%-14.64%-0.46%-5.03%1 Year Performance-58.44%-23.00%13.30%6.77% JATT Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JATTJATT AcquisitionN/A$1.28+18.5%N/A-84.3%$22.08MN/A0.003High Trading VolumePEPGPepGen2.5578 of 5 stars$2.50+19.6%$10.33+313.3%-84.0%$81.73MN/A-0.8430Gap UpJSPRJasper Therapeutics2.675 of 5 stars$5.35+1.3%$62.50+1,068.2%-79.0%$80.37MN/A-1.1320Short Interest ↓ZURAZura Bio2.1258 of 5 stars$1.22+2.5%$15.80+1,195.1%-57.5%$79.66MN/A0.003IFRXInflaRx2.5149 of 5 stars$1.18-0.8%$8.00+578.0%-19.3%$79.22M$168,498.00-1.0960Upcoming EarningsShort Interest ↑VTGNVistagen Therapeutics1.488 of 5 stars$2.72+2.6%N/A-33.5%$78.51M$698,000.00-1.8440SKYESkye Bioscience1.1492 of 5 stars$2.71-0.7%$18.67+588.8%-82.9%$77.06MN/A0.0011Positive NewsGap UpABOSAcumen Pharmaceuticals2.5961 of 5 stars$1.27+5.8%$9.33+634.9%-68.3%$76.30MN/A-0.9220Upcoming EarningsNews CoverageMGXMetagenomi1.4431 of 5 stars$2.02-1.5%$13.00+543.6%-84.4%$75.60M$55.08M0.00236Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageASRTAssertio1.9526 of 5 stars$0.77+1.4%$3.25+320.4%-31.0%$73.80M$125.76M-1.0620Analyst DowngradeAnalyst RevisionNews CoverageENTXEntera Bio2.323 of 5 stars$2.06+15.7%$10.00+385.4%+42.3%$73.72M$99,000.00-7.9220Analyst ForecastNews CoverageGap Up Remove Ads Related Companies and Tools Related Companies PEPG Alternatives JSPR Alternatives ZURA Alternatives IFRX Alternatives VTGN Alternatives SKYE Alternatives ABOS Alternatives MGX Alternatives ASRT Alternatives ENTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JATT) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JATT Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share JATT Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
